PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy (vol 128, pg 1413, 2018)

被引：24

作者：

Zamarin, Dmitriy

Ricca, Jacob M.

Sadekova, Svetlana

Oseledchyk, Anton

Yu, Ying

Blumenschein, Wendy M.

Wong, Jerelyn

Gigoux, Mathieu

Merghoub, Taha

Wolchok, Jedd D. ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
,11
,12
,13
,14
,15
,16
,17
,18
,19
,20
,21
,22
,23
,24
,25
,26
,27
]}

机构：

[1] Adapt Biotechnol, Seattle, WA USA

[2] Advaxis, Princeton, NJ USA

[3] Amgen Inc, Thousand Oaks, CA USA

[4] Array BioPharma, Boulder, CO USA

[5] Ascentage Pharma, Rockville, MD USA

[6] BeiGene, Hong Kong, Hong Kong, Peoples R China

[7] Bristol Myers Squibb, New York, NY USA

[8] Celgene, Summit, NJ USA

[9] Chugai Pharmaceut Co Ltd, Tokyo, Japan

[10] Eli Lilly & Co, Indianapolis, IN 46285 USA

[11] F Star, Cambridge, England

[12] Genentech Inc, San Francisco, CA USA

[13] Kleo Pharmaceut, New Haven, CT USA

[14] MedImmune, Gaithersburg, MD USA

[15] Merck, Kenilworth, NJ USA

[16] Neon Therapuet, Cambridge, MA USA

[17] Ono Pharmaceut Co, Osaka, Japan

[18] Polaris Pharma, San Diego, CA USA

[19] Polynoma, San Diego, CA USA

[20] PsiOxus Therapeut, Abingdon, Oxon, England

[21] PureTech Hlth, Boston, MA USA

[22] Recepta Biopharma SA, Sao Paulo, Brazil

[23] Trieza Therapeut, Cambridge, MA USA

[24] Sellas Life Sci, New York, NY USA

[25] Serametrix Immune Monitoring, Carlsbad, CA USA

[26] Surface Oncol, Cambridge, MA USA

[27] Syndax, Waltham, MA USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 11期

关键词：

D O I：

10.1172/JCI125039

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：5184 / 5184

页数：1

共 50 条

[31] Revisiting of Cancer Immunotherapy: Insight from the Dialogue between Glycolysis and PD-1/PD-L1 Axis in the Tumor Microenvironment
Liu, Qiong
Liu, Zihan
Zhang, Xi
Zeng, Anqi
Song, Linjiang
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2025, 21 (03): : 1202 - 1221
[32] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Iwai, Y
Ishida, M
Tanaka, Y
Okazaki, T
Honjo, T
Minato, N
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12293 - 12297
[33] Designed tumor microenvironment-remodeling bispolyphenol nanoparticles combined with αPD-L1 for enhanced melanoma immunotherapy
Wang, Yanzhu
Zang, Linghe
Guan, Liyuan
Ren, Xihang
Xia, Zongmin
Li, Zhou
Meng, Zhaoxu
Lian, He
Chemical Engineering Journal, 2025, 503
[34] Designed tumor microenvironment-remodeling bispolyphenol nanoparticles combined with αPD-L1 for enhanced melanoma immunotherapy
Wang, Yanzhu
Zang, Linghe
Guan, Liyuan
Ren, Xihang
Xia, Zongmin
Li, Zhou
Meng, Zhaoxu
Lian, He
CHEMICAL ENGINEERING JOURNAL, 2025, 503
[35] The role of PD-L1 in tumor microenvironment of merkel cell carcinoma
Mitteldorf, C.
Berisha, A.
Tronnier, M.
Pfaltz, M.
Kempf, W.
EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E81 - E82
[36] PD-L1 Expression and the Tumor Immune Microenvironment of Esophageal Adenocarcinomas
Thompson, Elizabeth
Taube, Janis
Cornish, Toby C.
Kelly, Ronan
Anders, Robert
LABORATORY INVESTIGATION, 2016, 96 : 203A - 203A
[37] PD-L1 expression and the tumor immune microenvironment in NUT carcinoma
Rooper, Lisa M.
London, Nyall R.
Taube, Janis M.
Westra, William H.
Bishop, Justin A.
Kang, Hyunseok
CANCER RESEARCH, 2019, 79 (13)
[38] PD-L1 Expression and the Tumor Immune Microenvironment of Esophageal Adenocarcinomas
Thompson, Elizabeth
Taube, Janis
Cornish, Toby C.
Kelly, Ronan
Anders, Robert
MODERN PATHOLOGY, 2016, 29 : 203A - 203A
[39] PD-1/PD-L1 axis importance and tumor microenvironment immune cells
Lotfinejad, Parisa
Kazemi, Tohid
Mokhtarzadeh, Ahad
Shanehbandi, Dariush
Niaragh, Farhad Jadidi
Safaei, Sahar
Asadi, Milad
Baradaran, Behzad
LIFE SCIENCES, 2020, 259
[40] Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumour microenvironment
Miles, J.
Gumuzio, J.
Calleja, V.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S99 - S100

← 1 2 3 4 5 →